SCHEMBL19785442

SCHEMBL19785442

Cc1nc(NCC2CCNCC2O)cnc1Sc1cccc(Cl)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.39
CDK1 P06493 2/20 0.38
CDK4 P11802 2/20 0.38
CCNE1 P24864 2/20 0.38
CDK2 P24941 2/20 0.38
CDK7 P50613 2/20 0.38
CDK9 P50750 2/20 0.38
CCNH P51946 2/20 0.38
MNAT1 P51948 2/20 0.38
CDK6 Q00534 2/20 0.38
CDK5 Q00535 2/20 0.38
CDK8 P49336 1/20 0.38
PTPN11 Q06124 13/20 0.38
KCNH2 Q12809 3/20 0.36
CCNT1 O60563 2/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19785441 1.00 IRAK4 (0.39) IRAK4CDK1CDK4CCNE1CDK2
SCHEMBL19785342 0.87 PTPN11 (0.41) IRAK4CDK9PTPN11KCNH2CCNT1
SCHEMBL25514417 0.87 PTPN11 (0.40) CCNE1CDK2CDK7CCNHMNAT1
SCHEMBL25514421 0.85 CCNT1 (0.45) IRAK4CDK9PTPN11KCNH2CCNT1
SCHEMBL19785567 0.85 PTPN11 (0.42) IRAK4CDK9PTPN11KCNH2CCNT1
SCHEMBL19785257 0.83 PTPN11 (0.38) PTPN11KCNH2CCNT1
SCHEMBL25514397 0.80 PTPN11 (0.44) PTPN11KCNH2CCNT1
SCHEMBL25514404 0.79 PTPN11 (0.43) PTPN11KCNH2CCNT1
SCHEMBL19785255 0.78 PTPN11 (0.40) PTPN11KCNH2CCNT1
SCHEMBL30295976 0.78 PTPN11 (0.40) PTPN11KCNH2CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018013597-A1 2,5-DISUBSTITUTED 3-METHYL PYRAZINES AND 2,5,6-TRISUBSTITUTED 3-METHYL PYRAZINES AS ALLOSTERIC SHP2 INHIBITORS Revolution Medicines, Inc. (US) 2018-01-18 WO disclosed